President Donald Trump has been heralding drugmakers as “great companies.” Yet in the final stretch of the presidential campaign, Trump is not feeling the love in pharma contributions. Former Vice President Joe Biden is, even though his proposed policies could dent the industry’s profitability.
Voting is a point of pride for many older Americans, and senior living facilities in past years have encouraged the civic act by hosting voting precincts, providing transportation to the polls and bringing in groups to help explain election issues. But fears of the spread of the coronavirus among this vulnerable population make voting more difficult this year.
President Donald Trump is one of at least two dozen people tied to the White House who have tested positive for COVID-19. Negotiations on the next round of COVID relief are off again — maybe. And the FDA and CDC continue to fight for scientific credibility. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Erin Mershon of Stat News join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews Amy Howe of SCOTUSblog about what the Supreme Court might do with the latest case challenging the constitutionality of the Affordable Care Act.
During this, the first and only vice presidential debate of the 2020 election season, the two candidates clashed over the coronavirus and other health care issues, as well as a range of other topics.
A 28-year-old Texas doctor tested positive in early July and died in September — one of a dozen young health workers nationwide whose deaths from the coronavirus have been profiled by KHN and The Guardian as part of the “Lost on the Frontline” project.
The president’s doctors have used HIPAA — the Health Insurance Portability and Accountability Act — as a shield to avoid questions about the president’s COVID-19 diagnosis.
Relentlessly knocked around by politics and now headed again to the Supreme Court, the ACA is covering millions who have lost their jobs during the pandemic. But not everyone.
These seniors use coping strategies to keep them socially active yet safe from the coronavirus.
California and at least five other states have said they may independently vet any vaccines. Experts warn that could needlessly confuse the public.